Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studyResearch in context by Georgia M. Parkin, Elizabeth A. Thomas, Jody Corey-Bloom

Get full text

Mapping neurodegeneration across the Huntington's disease spectrum: a five-year longitudinal analysis of plasma neurofilament lightResearch in context by Georgia M. Parkin, Elizabeth A. Thomas, Jody Corey-Bloom

Get full text

Exploring bradyphrenia in Huntington’s disease using the computerized test of information processing (CTiP) by Georgia M. Parkin, Braden Culbert, Emma Churchill, Paul E. Gilbert, Jody Corey-Bloom

Get full text

Salivary Huntingtin protein is uniquely associated with clinical features of Huntington’s disease by Georgia M. Parkin, Jody Corey-Bloom, Chase Snell, Haileigh Smith, Angela Laurenza, Manuel Daldin, Alberto Bresciani, Elizabeth A. Thomas

Get full text

The signal intensity variation of multiple sclerosis (MS) lesions on magnetic resonance imaging (MRI) as a potential biomarker for patients’ disability: A feasibility study by Sam Sedaghat, Sam Sedaghat, Hyungseok Jang, Jiyo S. Athertya, Martin Groezinger, Jody Corey-Bloom, Jiang Du, Jiang Du, Jiang Du

Get full text

Unraveling progressive verbal memory deficits in Huntington’s disease: insights from the LASSI-L by Luis A. Sierra, Japleen Kaur, Samuel A. Frank, Samuel A. Frank, Mark A. Halko, Mark A. Halko, Rosie E. Curiel Cid, David A. Loewenstein, Jody Corey-Bloom, Simon Laganiere, Simon Laganiere

Get full text

LASSI-L detects early cognitive changes in pre-motor manifest Huntington’s disease: a replication and validation study by Luis A. Sierra, Shelby B. Hughes, Shelby B. Hughes, Clementina J. Ullman, Andrew Hall, Sarbesh R. Pandeya, Robin Schubert, Samuel A. Frank, Samuel A. Frank, Mark A. Halko, Mark A. Halko, Jody Corey-Bloom, Simon Laganiere, Simon Laganiere

Get full text